Concepedia

Sarah Brockbank

SB

Statistics

Publications

14

Citations

1.9K

H-Index

13

Active since

1993

Affiliations

AstraZeneca (United Kingdom)(Current)

Nordic Bioscience (Denmark)

University of Southern Denmark

Imperial College London

GlaxoSmithKline (United Kingdom)

Sarah Brockbank is an author at AstraZeneca (United Kingdom) specializing in life sciences, osteoarthritis, and molecular biology.

Publications per year

1993–2022

14

Publications

14

Expression profiling of metalloproteinases and their inhibitors in cartilage

Lara Kevorkian, David A. Young, Clare Darrah et al. · Arthritis & Rheumatism · 2004 · 401 citations

, , +11

Characterisation of cell‐penetrating peptide‐mediated peptide delivery

Simon W. Jones, Richard Christison, Ken R. Bundell et al. · British Journal of Pharmacology · 2005 · 389 citations · Full text

, , +17

The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-α and MMP13

Simon W. Jones, Gareth M. Watkins, N. Le Good et al. · Osteoarthritis and Cartilage · 2008 · 320 citations · Full text

, , +12

Crystal Structure of Human MMP9 in Complex with a Reverse Hydroxamate Inhibitor

Siân Rowsell, Paul Hawtin, Claire A. Minshull et al. · Journal of Molecular Biology · 2002 · 257 citations

, , +9

Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: Prominent role of Wnt‐induced signaling protein 1

Arjen B. Blom, Sarah Brockbank, P.L. van Lent et al. · Arthritis & Rheumatism · 2009 · 238 citations

, , +17

1–5 of 14